Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
January 29, 2018 Off

Sanofi buys Ablynx for €3,9 billion

By Dino Mustafić

Sanofi will buy Belgian Nanobody technology specialist Ablynx for €3.9 billion, it was announced Monday by both companies. 

Bormioli Pharma packaging innovations finds solution to unstable drug formulations
January 29, 2018 Off

Bormioli Pharma packaging innovations finds solution to unstable drug formulations

By Dino Mustafić

This year’s Pharmapack Conference sees Bormioli Pharma, one of the world’s leading glass and plastic packaging manufacturers for the pharmaceutical sector, make a…

January 29, 2018 Off

Santhera reports net revenues 21% up in 2017 from its lead product Raxone, amid negative opinion by CHMP for it in DMD

By Dino Mustafić

Santhera Pharmaceuticals has reported an increase of 21% year-on-year in net revenues to CHF 22.9 million (2016: CHF 19.0 million)…

January 29, 2018 Off

Faron’s Traumakine on Fast Track, as the US FDA says it’s good to go

By Dino Mustafić

Faron Pharmaceuticals has received Fast Track designation from the US Food and Drug Administration (FDA) for Traumakine, which also has…

OxforD BioDynamics develops with Holos Life Sciences biomarkers for sport-related concussions
January 29, 2018 Off

OxforD BioDynamics develops with Holos Life Sciences biomarkers for sport-related concussions

By Dino Mustafić

Oxford BioDynamics and Holos Life Sciences will together develop non-invasive epigenetic biomarkers associated with sports-related concussions, Oxford said Monday.

EMA confirms negative stand for Santhera’s Raxone extension application in Duchene
January 26, 2018 Off

EMA confirms negative stand for Santhera’s Raxone extension application in Duchene

By Dino Mustafić

Santhera Pharmaceuticals will still remain without extension application for Raxone in Duchenne muscular dystrophy (DMD) in Europe, as expected. The…

Phase three trial shows AstraZeneca’s COPD treatment improves lung functions
January 26, 2018 Off

Phase three trial shows AstraZeneca’s COPD treatment improves lung functions

By Dino Mustafić

AstraZeneca Friday said its Phase III KRONOS trial showed that PT010 improvement compared with dual combination therapies in six out…

January 25, 2018 Off

Endo pauses lawsuit against FDA until end of March

By Dino Mustafić

Endo International Wednesday said stay of the litigation against FDA made in October 2017 by its subsidiaries, Par Sterile Products, LLC and…

GW conducts study showing the potential of cannabidiol in reducing seizures
January 25, 2018 Off

GW conducts study showing the potential of cannabidiol in reducing seizures

By Dino Mustafić

GW Pharmaceuticals and its U.S. subsidiary Greenwich Biosciences, have conducted a study which showed the potential of cannabidiol in reducing…

Novartis gets outside US rights for first of the kind vision restoring treatment
January 25, 2018 Off

Novartis gets outside US rights for first of the kind vision restoring treatment

By Dino Mustafić

Novartis on Wednesday said it has made a with deal Spark Therapeutics about the rights for voretigene neparvovec in markets…

Posts pagination

Previous 1 … 3,411 3,412 3,413 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine